bioRxivCancer BiologyPreprint
G6PD deficiency sensitizes metastasizing melanoma cells to oxidative stress and glutaminolysis
A. B. Aurora, V. Khivansara, A. Leach, J. G. Gill, M. Martin-Sandoval, C. Yang, S. Y. Kastininon, D. Bezwada, A. Tasdogan, W. Gu, T. P. Mathews, Z. Zhao, R. J. DeBerardinis, S. J. Morrison
Abstract
The pentose phosphate pathway is a major source of NADPH for oxidative stress resistance in cancer cells but there is limited insight into its role in metastasis, when some cancer cells experience high levels of oxidative stress. To test this, we mutated the substrate binding site of Glucose-6-phosphate dehydrogenase (G6PD), which catalyzes the first step of the pentose phosphate pathway, in patient-derived melanomas. G6PD mutant melanomas had significantly decreased G6PD enzymatic activity and depletion of intermediates in the oxidative branch of the pentose phosphate pathway. Reduced G6PD function had little effect on the formation of primary subcutaneous tumors but when these tumors spontaneously metastasized the frequency of circulating melanoma cells in the blood and metastatic disease burden were significantly reduced. G6PD mutant melanomas exhibited increased levels of reactive oxygen species (ROS), decreased NADPH levels, and depleted glutathione as compared to control melanomas. G6PD mutant melanomas compensated for this increase in oxidative stress by increasing the production of NADPH through glutaminolysis. This generated a new metabolic vulnerability as G6PD mutant melanomas were more dependent upon glutamine as compared to control melanomas. The oxidative pentose phosphate pathway and compensatory glutaminolysis thus confer layered protection against oxidative stress during metastasis. SignificanceMelanoma metastasis is limited by oxidative stress. Cells that enter the blood experience high levels of ROS and usually die of ferroptosis. We found that melanoma cells become more dependent upon the oxidative branch of the pentose phosphate pathway to manage oxidative stress during metastasis. When pentose phosphate pathway function was disabled by G6PD mutation, the melanoma cells increased their utilization of malic enzyme, fueled by increased consumption of glutamine in the tricarboxylic acid cycle. Melanoma cells thus have redundant and layered protection against oxidative stress.
- organism: human
- assay: metabolomics
- research focus: cancer & tumor microenvironment
- research focus: metabolism & bioenergetics
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oxidative Phosphorylation (OXPHOS) Promotes the Formation and Growth of Melanoma Lung and Brain Metastases
Renato A. Guerrieri, Grant M. Fischer, … Michael A. Davies·bioRxiv·Jan 23, 2025
- G6PD Inhibition Sensitizes Ovarian Cancer Cells to Oxidative Stress in the Metastatic Omental Microenvironment
- Glucose-6-phosphate dehydrogenase deficiency accelerates pancreatic acinar-to-ductal metaplasia
M. D. Radyk, B. S. Nelson, … C. A. Lyssiotis·bioRxiv·Nov 6, 2023
- G6PD Maintains Redox Homeostasis and Biosynthesis in LKB1-Deficient KRAS-Driven Lung Cancer
- Transcriptional Isoforms of NAD+ Kinase regulate oxidative stress resistance and melanoma metastasis
G. Cascio, K. Aguirre, … E. Piskounova·bioRxiv·Feb 2, 2023
- Antagonistic functions of the two oxidative pentose phosphate pathway dehydrogenases in shaping oxidative stress responses
Lug Trémulot, Zheng Yang, … Graham Noctor·bioRxiv·May 5, 2026